CD34 and leukemia: That said, establishing a diagnosis of morphologic CR or morphologic leukemia-free state (MLFS) based on blast counts after therapy however is particularly problematic in TP53MUT MN where significant erythroid-predominant leukemic hematopoiesis (often CD34-/strong p53 + ) is frequently observed.